These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35697134)

  • 1. Towards replacement of animal tests with in vitro assays: a gene expression biomarker predicts in vitro and in vivo estrogen receptor activity.
    Corton JC; Liu J; Kleinstreuer N; Gwinn MR; Ryan N
    Chem Biol Interact; 2022 Aug; 363():109995. PubMed ID: 35697134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
    Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS
    Environ Sci Technol; 2015 Jul; 49(14):8804-14. PubMed ID: 26066997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 50-gene biomarker identifies estrogen receptor-modulating chemicals in a microarray compendium.
    Corton JC; Matteo G; Chorley B; Liu J; Vallanat B; Everett L; Atlas E; Meier MJ; Williams A; Yauk CL
    Chem Biol Interact; 2024 May; 394():110952. PubMed ID: 38570061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.
    Judson RS; Houck KA; Watt ED; Thomas RS
    Regul Toxicol Pharmacol; 2017 Dec; 91():39-49. PubMed ID: 28993267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
    Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
    Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.
    Ryan N; Chorley B; Tice RR; Judson R; Corton JC
    Toxicol Sci; 2016 May; 151(1):88-103. PubMed ID: 26865669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.
    Nelms MD; Antonijevic T; Ring C; Harris DL; Bever RJ; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Edwards SW; Markey K
    Front Toxicol; 2024; 6():1346767. PubMed ID: 38694816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.
    Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS
    Toxicol Sci; 2015 Nov; 148(1):137-54. PubMed ID: 26272952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses.
    Rotroff DM; Martin MT; Dix DJ; Filer DL; Houck KA; Knudsen TB; Sipes NS; Reif DM; Xia M; Huang R; Judson RS
    Environ Sci Technol; 2014; 48(15):8706-16. PubMed ID: 24960280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational analysis of the ToxCast estrogen receptor agonist assays to predict vitellogenin induction by chemicals in male fish.
    Dreier DA; Denslow ND; Martyniuk CJ
    Environ Toxicol Pharmacol; 2017 Jul; 53():177-183. PubMed ID: 28645054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential endocrine disrupting chemicals using gene expression biomarkers.
    Corton JC; Kleinstreuer NC; Judson RS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114683. PubMed ID: 31325560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signature analysis of high-throughput transcriptomics screening data for mechanistic inference and chemical grouping.
    Harrill JA; Everett LJ; Haggard DE; Word LJ; Bundy JL; Chambers B; Harris F; Willis C; Thomas RS; Shah I; Judson R
    Toxicol Sci; 2024 Nov; 202(1):103-122. PubMed ID: 39177380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells.
    Rotroff DM; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Reif DM; Richard AM; Sipes NS; Abassi YA; Jin C; Stampfl M; Judson RS
    Chem Res Toxicol; 2013 Jul; 26(7):1097-107. PubMed ID: 23682706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate reference chemicals for in vitro steroidogenesis assays.
    Pinto CL; Markey K; Dix D; Browne P
    Toxicol In Vitro; 2018 Mar; 47():103-119. PubMed ID: 29146384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening tools facilitate calculation of a combined exposure-bioactivity index for chemicals with endocrine activity.
    Wegner SH; Pinto CL; Ring CL; Wambaugh JF
    Environ Int; 2020 Apr; 137():105470. PubMed ID: 32050122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 rodent uterotrophic and Hershberger assays.
    Marty MS; O'Connor JC
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):63-79. PubMed ID: 24515841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alginate Immobilization of Metabolic Enzymes Platform Retrofits an Estrogen Receptor Transactivation Assay With Metabolic Competence.
    Deisenroth C; DeGroot DE; Zurlinden T; Eicher A; McCord J; Lee MY; Carmichael P; Thomas RS
    Toxicol Sci; 2020 Dec; 178(2):281-301. PubMed ID: 32991717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.